02696nas a2200265   4500000000100000008004100001260001200042653001700054653001900071653001400090653001000104653001500114653001600129653001900145653001600164100001400180700001300194700001400207245008600221856008700307300000700394490000600401520200900407022001402416       2020                            d  c01/202010aEpidemiology10aHealth systems10aIncidence10aIndia10aPrevalence10aSnake Bites10aeconomic costs10arisk factor1 aBhaumik S1 aNorton R1 aJagnoor J00aBurden and risk factors for snakebite in India: protocol for a systematic review.  uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194469/pdf/f1000research-9-25296.pdf  a250 v93 a<p> Snakebite is a neglected tropical disease with a high burden in South and South-East Asia and sub-Saharan Africa. In 2019, the World Health Organization (WHO) released a roadmap which aims for a 50% reduction in death and disability due to snakebite globally by 2030. It is estimated that India has the highest number of snakebite deaths in the world.  To synthesize evidence on the burden (incidence/ prevalence, mortality, morbidity, health facility and economic), and risk factors for snakebite in India.  We will search for peer-reviewed literature and grey literature in six electronic databases (MEDLINE, EMBASE, Global Health, PsychInfo, CENTRAL, SafetyLit) and hand-search IndMed, conference abstracts, relevant websites and citation tracking. Two reviewers will screen and extract data independently with a third reviewer acting as an arbiter for any inconsistencies. Quality of the included studies will be assessed using the Joanna Briggs Institute (JBI) critical appraisal tools. For burden, data from facility based and community-based studies will be synthesised and reported separately, except for studies conducted concurrently. We will conduct meta-analysis for community-based studies at state-level for incidence/prevalence, mortality and morbidity , if appropriate. The PROGRESS Plus lens will be used to explore equity . Analyses for each individual risk factor-outcome pair will be conducted and reported separately. If appropriate, meta-analyses will be conducted as per JBI guidelines, assessing heterogeneity using Tau-squared, Cochran's Q test and Chi-squared (p > 0.05) tests. We plan to conduct sub-group analyses based on pre-specific parameters. A funnel plot will be generated if there are more than nine studies included in a specific meta-analysis, to assess publication bias When meta-analysis is not appropriate, structured tabulation of results across studies and/or by vote counting based on the direction of effect as per guidelines in the Cochrane Handbook.</p>  a2046-1402